Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Phase 3 Completed 60 enrolled Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to study the effect of two doses of olmesartan medoxomil and amlodipine on vascular markers in hypertensive patients with metabolic syndrome.

Timeline

Start: 2008-10
Primary completion: 2011-04
Completion: 2011-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Amlodipine	Other / unclassified	—	—
Subject	Olmesartan medoxomil	Unknown	—	—

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Summary

Timeline

Drugs

Indications